Monostotic fibrous dysplasia
| Monostotic fibrous dysplasia | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Bone pain, deformity, fractures |
| Complications | Osteosarcoma (rare) |
| Onset | Childhood |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation in the GNAS gene |
| Risks | |
| Diagnosis | X-ray, CT scan, MRI, Bone biopsy |
| Differential diagnosis | Osteofibrous dysplasia, Osteosarcoma, Paget's disease of bone |
| Prevention | N/A |
| Treatment | Bisphosphonates, Surgery |
| Medication | Bisphosphonates |
| Prognosis | Generally good, but varies |
| Frequency | Rare |
| Deaths | N/A |
Monostotic fibrous dysplasia is a rare bone disease characterized by the replacement of medullary bone with fibrous tissue, causing the expansion and weakening of the areas of the skeleton where it occurs. It is a type of fibrous dysplasia of bone, and is the most common form, accounting for about 70% of all cases.
Signs and Symptoms[edit]
Patients with monostotic fibrous dysplasia usually present with painless bony swelling. The disease is often asymptomatic and is discovered incidentally on radiographs. When symptoms do occur, they are often mild and nonspecific, including bone pain, bone deformity, and pathological fractures.
Causes[edit]
Monostotic fibrous dysplasia is caused by a mutation in the GNAS1 gene, which leads to overproduction of fibrous tissue in the bone. This mutation is not inherited, but occurs randomly during a person's lifetime.
Diagnosis[edit]
Diagnosis of monostotic fibrous dysplasia is typically made based on the characteristic appearance of the affected bone on radiographs. Additional imaging studies, such as CT or MRI, may be used to further evaluate the extent of the disease. A biopsy of the affected bone may also be performed to confirm the diagnosis.
Treatment[edit]
There is currently no cure for monostotic fibrous dysplasia. Treatment is aimed at managing symptoms and preventing complications. This may include pain management, physical therapy, and in some cases, surgical intervention to correct bone deformities or stabilize fractures.
Prognosis[edit]
The prognosis for individuals with monostotic fibrous dysplasia is generally good. The disease is typically slow-growing and does not spread to other bones. However, it can cause significant morbidity due to bone pain, deformity, and fractures.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


